Fraud in breast-cancer trials
Bernier, G.M.
New England Journal of Medicine 330(20): 1461
1994
ISSN/ISBN: 0028-4793 PMID: 8159209 Document Number: 438534
Document emailed within 1 workday
Related Documents
Poisson, R. 1994: Fraud in breast-cancer trials New England Journal of Medicine 330(20): 1460Werkö, L. 1994: Fraud in cancer studies. more stringent control required. the risk of fraud is increased by commercialization Lakartidningen 91(32-33): 2862-2864
Cheson, B.D.; Abrams, J.S.; Arbuck, S.G.; Phillips, P.H. 1994: Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer Oncology 8(1): 72
Cheson, B.D. 1989: Clinical trials referral resource. Adjuvant therapy of breast cancer Oncology 3(6): 70
Cuzick, J.; Stewart, H.; Peto, R.; Baum, M.; Fisher, B.; Host, H.; Lythgoe, J.P.; Ribeiro, G.; Scheurlen, H.; Wallgren, A. 1987: Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer Cancer Treatment Reports 71(1): 15-29
Cheson, B.D.; Phillips, P.H.; Abrams, J. 1994: Clinical trials referral resource. Adjuvant therapy in breast cancer Oncology 8(11): 55; 60, 65
Bruzzi, P. 1998: Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue Bmj 316(7139): 1181-1182
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
1988: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women New England Journal of Medicine 319(26): 1681-1692
Clement, N.J.; Williams, D.E.; Sanders, D.; Aspey, D. 1992: Are Medicaid fraud control units the real fraud: 4. Penetrating the deceptions Journal of Clinical Pediatric Dentistry 16(2): 129-147
May, D. 2010: The new fraud offensive. It's time to stop losing billions to fraud each year and redirect those dollars Modern Healthcare 40(26): 26
Clement, N.J.; Williams, D.E.; Sanders, D. 1991: Are Medicaid fraud control units the real fraud, Part 3? Bias, distortions and misplaced analyses Journal of Clinical Pediatric Dentistry 16(1): 48-59
Taylor, M. 2002: Some fraud fight left. Proposed HCA settlement, other enforcement activities indicate feds still serious about fighting healthcare fraud Modern Healthcare 32(51): 6-7; 12-13, 1
Taylor, M. 2002: Some fraud fight left. Proposed HCA settlement, other enforcement activities indicate feds still serious about fighting healthcare fraud Modern Healthcare 32(51): 6-7; 12-13, 1
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Chlebowski, R.T.; Rohan, T.E.; Manson, J.E.; Aragaki, A.K.; Kaunitz, A.; Stefanick, M.L.; Simon, M.S.; Johnson, K.C.; Wactawski-Wende, J.; O'Sullivan, M.J.; Adams-Campbell, L.L.; Nassir, R.; Lessin, L.S.; Prentice, R.L. 2015: Breast Cancer After use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data from 2 Women's Health Initiative Randomized Clinical Trials JAMA Oncology 1(3): 296-305
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Pierce, J.P. 2009: Diet and breast cancer prognosis: making sense of the Women's Healthy Eating and Living and Women's Intervention Nutrition Study trials Current Opinion in Obstetrics and Gynecology 21(1): 86-91
Bria, E.; Vanni, B.; Cuppone, F.; Calabretta, F.; Campanella, C.; Torsello, A.; Terzoli, E. 2004: Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab I Supplementi di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S65-S66